Cancer of unknown primary in the era of precision medicine
The organising committee are delighted to invite you to this virtual symposium which will focus on cancer of unknown primary (CUP). We are particularly interested in the use of personalised medicine by way of genomic profiling and ‘molecular tumour board’ meetings to determine the best treatment and management options for patients.
We are hoping to provide an opportunity for attendees to improve their understanding of research, diagnosis, and treatment of CUP.
This symposium promises high quality talks both clinically and scientifically.Our first Session is themed ‘What’s Next for CUP?’ and focuses on patient experience and research. We are very lucky to have three outstanding expert international plenary speakers: Dr. Jean Claude Zenklusen, Director of The Cancer Genome Atlas, Dr. Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute, and John Symons, Director of the Cancer of Unknown Primary Foundation Jo’s Friends.
The second session features three in-house SVUH clinical specialists who will detail current practice and available treatment options. To round off the event, a ‘molecular tumour board’ formed of all speakers and chairs will discuss the first case of the SJKF CUP study currently running in SVUH.
We would be delighted for you to join us to share experiences, ideas and achievements.
This free event is aimed at oncologists, pathologists, nurses, academics, policy makers and all those with an interest in this area.
Application made for CPD and CEU points.
Registration is not currently available.